• Policy
• Drug price negotiation completed 307 drugs in 2022
• by Lee, Tak-Sun Sep 16, 2022 05:53am

• Policy
• “GOV to prove causal relationship of vaccine side effects"
• by Lee, Jeong-Hwan Sep 16, 2022 05:53am

• Policy
• The introduction of Moderna COVID-19 vaccine has begun
• by Kim, Jung-Ju Sep 16, 2022 05:53am

• Policy
• The flu-coronavirus outbreak has been predicted
• by Kim, Jung-Ju Sep 15, 2022 05:55am

• Policy
• Lowest price falls to PVA
• by Lee, Tak-Sun Sep 14, 2022 05:50am

• Policy
• GOV·Pharma starts work to localize 57 essential medicines
• by Lee, Jeong-Hwan Sep 13, 2022 05:52am

• Policy
• Paxlovid is contraindicated with other concomitant meds
• by Lee, Tak-Sun Sep 13, 2022 05:51am

• Policy
• Approval of Boryung’s new SCLC drug Zepzelca imminent
• by Lee, Hye-Kyung Sep 8, 2022 05:58am

• Policy
• MOHW to provide premium pricing support for innovative drugs
• by Lee, Jeong-Hwan Sep 7, 2022 05:52am

• Policy
• What's patient-centered safety in the biopharmaceutical era?
• by Lee, Hye-Kyung Sep 7, 2022 05:52am